Pharmaceutical Manufacturing
Pharmaceutical companies, which develop both over-the-counter and prescription drugs, have been among the biggest political spenders for years. While the industry has traditionally supported Republican candidates, some key players have recently increased donations to Democratic candidates as the GOP’s power in Washington erodes.
The pharmaceutical manufacturing industry will likely fair better this decade now that President Barack Obama’s initial plan to institute a public health insurance did not become a part of sweeping health care reform legislation signed into law in 2010. A government-run plan, because of its size, would have had considerable negotiating power to draw down drug prices. [Read more Background]
Top Contributors, 2011-2012
Contributor Amount Pfizer Inc $702,391
Amgen Inc AstraZeneca PLC Abbott Laboratories Merck & Co GlaxoSmithKline Eli Lilly & Co Novartis AG Bayer Corp Endo Pharmaceuticals Perrigo Co Mutual Pharmaceutical Allergan Inc Teva Pharmaceuticals USA Sanofi-Aventis Bristol-Myers Squibb Pharmaceutical Rsrch & Mfrs of America Nostrum Pharmaceuticals Cephalon Inc Takeda Pharmaceuticals North America Top Recipients, 2011-2012
Candidate Office Amount Obama, Barack (D) $129,139
Romney, Mitt (R) $89,300
Upton, Fred (R-MI) House Brown, Scott P (R-MA) Senate Hatch, Orrin G (R-UT) Senate Data for the current election cycle were released by the Federal Election Commission on Monday, February 13, 2012
Feel free to distribute or cite this material, but please credit the Center for Responsive Politics.
Saturday, March 10, 2012
Lobbying by Pharmaceutical Manufacturing | OpenSecrets
via opensecrets.org
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment